Functional differences of short and long isoforms of spastin harboring missense mutation by Plaud, Clement et al.
HAL Id: hal-02166828
https://hal-univ-evry.archives-ouvertes.fr/hal-02166828
Submitted on 18 Oct 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Functional differences of short and long isoforms of
spastin harboring missense mutation
Clement Plaud, Vandana Joshi, Natallie Kajevu, Christian Poüs, Patrick
Curmi, Andrea Burgo
To cite this version:
Clement Plaud, Vandana Joshi, Natallie Kajevu, Christian Poüs, Patrick Curmi, et al.. Functional
differences of short and long isoforms of spastin harboring missense mutation. Disease Models &
Mechanisms, Cambridge Company of Biologists, 2018, 11 (9), pp.dmm033704. ￿10.1242/dmm.033704￿.
￿hal-02166828￿
RESEARCH ARTICLE
Functional differences of short and long isoforms of spastin
harboring missense mutation
Clément Plaud1, Vandana Joshi1, Natallie Kajevu1, Christian Poüs2, Patrick A. Curmi1 and Andrea Burgo1,*
ABSTRACT
Mutations of the SPG4 (SPAST) gene encoding for spastin protein
are the main causes of hereditary spastic paraplegia. Spastin binds to
microtubules and severs them through the enzymatic activity of its
AAA domain. Several missense mutations located in this domain
lead to stable, nonsevering spastins that decorate a subset of
microtubules, suggesting a possible negative gain-of-function
mechanism for these mutants. Of the two main isoforms of spastin,
only mutations of the long isoform, M1, are supposed to be involved in
the onset of the pathology, leaving the role of the ubiquitously
expressed shorter one, M87, not fully investigated and understood.
Here, we show that two isoforms of spastin harboring the same
missense mutation bind and bundle different subsets of microtubules
in HeLa cells, and likely stabilize them by increasing the level of
acetylated tubulin. However, only mutated M1 has the ability to
interact with wild-type M1, and decorates a subset of perinuclear
microtubules associated with the endoplasmic reticulum that display
higher resistance to microtubule depolymerization and increased
intracellular ionic strength, compared with those decorated by
mutated M87. We further show that only mutated M1 decorates
microtubules of proximal axons and dendrites, and strongly impairs
axonal transport in cortical neurons through a mechanism likely
independent of the microtubule-severing activity of this protein.
KEY WORDS: Spastin, SPG4, HSP, Missense mutations,
Microtubules
INTRODUCTION
Hereditary spastic paraplegias (HSPs) are a group of monogenic
inherited neurological disorders characterized by lower-limb
spasticity and stiffness. Neurodegeneration of corticospinal tract
axons and ascending sensor fibers are, to date, the main neuronal
defects observed in postmortem patients. More than 70 distinct loci
have been linked to HSPs. However, 40% of autosomal dominant
and 20% of sporadic cases of all HSPs depend on mutations in the
spastic paraplegia 4 (SPG4 or SPAST) gene, which encodes the
protein spastin (Lo Giudice et al., 2014). Microtubule (MT)
severing is the main known function of spastin. It requires at least
the MT-binding domain [MTBD; amino acids (aa) 270-328] and
the MT-severing ATPase associated with various cellular activities
(AAA) module (aa 343-616) (Roll-Mecak and Vale, 2005; White
et al., 2007). In addition, spastin is endowed with MT-bundling
activity independent of ATP hydrolysis (Salinas et al., 2005).
SPG4 mRNA mainly directs the synthesis of two main isoforms
owing to the presence of alternative start sites: the full-length M1
isoform (616 aa) and the shorter M87, which lacks the first 87 aa
(Claudiani et al., 2005). Thanks to its N-terminal hydrophobic
region (Park et al., 2010), M1 likely spans the outer leaflet of the
endoplasmic reticulum (ER) membranes, whereas M87 is soluble.
In rodents, although both isoforms are widely expressed, M87 is
always the more abundant in all tissues, whereas M1 is enriched in
brain and spinal cord (Claudiani et al., 2005; Solowska et al.,
2008). Nevertheless, both isoforms bind MTs and may form ring-
shaped oligohexamers, which are needed to perform MT severing
(Roll-Mecak and Vale, 2008). Among more than 300 different
mutations found in SPG4, ∼30% are missense mutations located in
the AAA cassette. Several point mutations in the AAA domain
often result in severing-incompetent M1 spastin, which decorates
and bundles a subset of MTs (Errico et al., 2002; McDermott et al.,
2003; Evans et al., 2005; Roll-Mecak and Vale, 2005; White et al.,
2007; Pantakani et al., 2008; Solowska et al., 2014). Such mutants
are kinetically stable, not degraded, and can affect both MT
dynamics and fast axonal transport (Solowska et al., 2008;
Solowska et al., 2014; Leo et al., 2017). To date, two molecular
mechanisms can explain the effects of these mutants. In the
haploinsufficiency model for HSP-SPG4 (haploinsufficiency
remains the prevalent mechanism proposed to explain the
disease), a 50% reduction in active spastin levels (inactivation of
one allele) would account for lower MT severing (Hazan et al.,
1999; Bürger et al., 2000; Fonknechten et al., 2000). Alternatively,
mutated spastin, such as mentioned above, can exert a dominant-
negative effect by forming defective heterohexamers with wild-
type (WT) spastin (Eckert et al., 2012a,b; Le et al., 2013; Solowska
and Baas, 2015). However, the latter hypothesis is still a matter of
debate, and whether the mutated spastin can effectively impair the
enzymatic activity of WT spastin is unclear (Solowska and Baas,
2015). Also, whether the two isoforms contribute differently to the
onset and/or progression of the disease is essentially unknown, but
it has been suggested that M87 might be less involved than M1.
Such a conclusion was supported by the observations that M1 is
enriched in spinal cord in rodents, and by the lack of effects of
mutated M87 on axonal transport and neurite growth (Solowska
et al., 2008, 2014; Leo et al., 2017). The actual proposed
explanation for this lower toxicity is that, in a dominant-negative
scenario, M87 likely harbors the same AAA mutations as the
longer isoform, but it is somehow degraded more effectively
than mutated M1 (Solowska et al., 2010, 2017). In addition, it is
not known whether mutated M87 could form heterohexamers
with WT M1.Received 22 January 2018; Accepted 3 July 2018
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Here, we demonstrate that for the same pathological missense
mutation, the long M1 and the shorter M87 (M85 in mouse)
isoforms of spastin decorate and bundle two different subsets of
MTs in HeLa cells. We further show that mutated M85 is mainly
diffuse in the cytoplasm of cortical neurons and less resistant than
mutated M1 to pharmacological treatments. Finally, only mutated
M1 interacts with and redistributes WT spastin, likely through
heterohexamer ring formation, and strongly impairs the transport of
axonal cargos.
RESULTS
M1CY and M85CY decorate different subsets of MTs
Mutations ofM1 spastin, but not those of the short isoformM87, are
considered the main causes of HSP linked to SPG4 (Solowska et al.,
2014; Leo et al., 2017). Despite the extensive literature on spastin,
very little is known about the role of mutated M87 in this pathology.
To investigate whether, for the same mutation, M1 and M87 (M85
in mice) differ in their intracellular localization and biophysical
properties, we generated WT constructs, that were C-terminally
tagged with GFP or Flag, of these two isoforms (Fig. S1A), as well
as constructs harboring the missense mutation C448Y (C445Y in
mice), which has been previously described (Errico et al., 2002;
White et al., 2007; Solowska et al., 2014; Leo et al., 2017) and
found in HSP-SPG4 patients (Hazan et al., 1999; Fonknechten et al.,
2000). We also prepared a truncated form of M1 without the entire
AAA cassette (aa 1-338; M1Δ), which mimics the presence of a
premature stop codon, and a construct coding the first N-terminal 85
aa (N-Ter) containing the hydrophobic region (HR), likely forming
an ER intramembrane hairpin loop (Park et al., 2010). Constructs
were transfected in HeLa cells and fixed, and then cells were stained
for β-tubulin for their characterization. As expected, theWT form of
M1 (M1WT) showed a typical perinuclear distribution with puncta
and clusters (Errico et al., 2002; McDermott et al., 2003), whereas
that of M85 (M85WT) was predominantly cytosolic (Fig. S1B).
Both constructs efficiently severed MTs, but to a higher extent for
M85 (Solowska et al., 2008). M1-C445Y (M1CY) exhibited either
a filamentous (86% of 308 M1CY-expressing cells analyzed) or a
puncta-filamentous (∼13%) pattern and decorated mainly a subset
of MTs that rarely extend at the peripheral area of the cells (Fig. 1),
consistent with previous reports for the same mutation (Errico et al.,
2002; White et al., 2007; Solowska et al., 2014). M85-C445Y
(M85CY) also distributed into a filamentous pattern (91% of 268
M85CY-expressing cells analyzed; the others showed a cytosolic
staining) but decorated a limited subset of MTs, which were more
peripheral and clustered compared with those decorated by M1CY.
Whereas perinuclear bundles displayed highly curved morphology,
peripheral ones are often straight, perpendicular and oriented radial.
M1Δ decorated a larger population of MTs compared with M1CY
andM85CY, in agreement with previous results (Errico et al., 2002;
White et al., 2007), but in contrast to unpublished observations in
RTL-6 fibroblasts (Solowska et al., 2014). M1Δ distribution is more
complex than that for M1CY or M85CY, with puncta, filamentous
or puncta-filamentous pattern (18%, 29% and 53% of 270 M1Δ-
expressing cells analyzed, respectively). Moreover, M1WT and its
mutants also delimitate ring-shaped empty structures that were
filled by boron-dipyrromethene (BODIPY) (Fig. S2), which were
particularly frequent inM1Δ-expressing cells (Fig. 1, green outlined
inset), confirming the involvement of this isoform in lipid droplet
metabolism (Papadopoulos et al., 2015). Co-expression of Flag-
tagged M1CY and M85CY-GFP further showed that the two
mutated isoforms decorated a different subset of MTs (Fig. 1B,C),
which partly overlap, M1CY being specifically associated with a
perinuclear cage of MTs and M85CY with straight peripheral MT
bundles. To further verify that M85CY was specifically targeted to
peripheral MT, we started imaging cells early after transfection. As
shown in Fig. 1D andMovie 1, M85CY early accumulated to a high
level on MT bundles (both on the intercellular bridge of telophase
cells and on peripheral bundles), suggesting that it directly targeted
specific features of such MTs.
M1CY and M85CY sequences differ only by their first 85 aa.
This N-terminal region contains the HR, allowing M1 spastin to be
inserted into the ER membrane as previously demonstrated (Park
et al., 2010; Blackstone et al., 2011), and shown here by the
expression of a construct containing only this domain (N-Ter-GFP;
Fig. 2A). M85WT lacks this region and therefore shows a cytosolic
distribution pattern. As expected and confirmed by colocalization
analysis (Fig. 2B), both M1 mutants extensively colocalize with the
ER, which appears particularly bundled and co-aligned with MTs in
cells expressing M1Δ. On the contrary, M85CY-positive filaments
do not overlap with ER membranes, suggesting that the subset of
MTs decorated by M85CY is not, or differently, implicated in ER
dynamics. Taken together, these data indicate that in HeLa cells,
M1CY is inserted in the ER and decorates perinuclear MTs,
whereas M85CY binds directly to a peripheral MT subset likely not
involved in ER dynamics. The absence of an AAA cassette does not
prevent MT decoration and bundling.
M85CY is mainly cytosolic in cortical neurons
In order to understand whether the specific pattern of spastin mutants
observed in HeLa cells were reproduced in neurons, the same
constructs were expressed in mouse cortical neurons in primary
culture at 4 days in vitro (DIV). Owing to MT-severing activity, the
expression of M1WT and M85WT was highly toxic and only a few
neurons expressing M1WT with regular morphology have been
found. Nevertheless, M1WT showed a typical punctate vesicular
perinuclear pattern as shown above in HeLa cells (Fig. S3A). M1CY
formed typical filamentous bundles which were restricted mainly to
proximal axons and dendrites, whereas M1Δ decorated longer
segments of mainly axonal MTs (Fig. 3). M1CY staining was also
often more discontinuous with segments of different lengths
(Fig. S3B). On the contrary, M85CY showed a lower propensity to
decorate MTs and appeared mainly cytosolic and enriched distally
when compared with M1CY (see also Fig. S3B). We did not observe
significant change in neuronal morphology induced by expression of
these mutated forms of spastin, even 72 h after transfection (data not
shown). Co-transfection of Flag-tagged M1CY and M85CY-GFP
confirms that the two mutated isoforms localize differently in cortical
neurons (Fig. 3B).
These results confirm a different localization of spastin mutants
in cortical neurons as observed in HeLa cells and suggest a weaker
affinity of M85CY for MTs in comparison to M1 mutants.
Spastin mutants increase the level of acetylated tubulin
Acetylation is a post-translational modification (PTM) of tubulin
frequently associated with long-lived MTs (Janke, 2014). Missense
mutations of M1 spastin have been associated with increased
stabilization of the MT network (Evans et al., 2005). Accordingly,
we observed that the expression of all spastin mutants significantly
increased the level of acetylated tubulin (Fig. 4). Quantification of
the average intensity of acetylated tubulin in M1CY-, M85CY- and
M1Δ-expressing cells demonstrated an increase of this PTM by
59.3±4.7%, 100.4±8.3% and 46±5.1%, respectively. This effect
seems to be strictly specific for acetylation because tyrosinated
(Fig. S4) and total β-tubulin are not altered (Fig. 5C). As expected,
2
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033704. doi:10.1242/dmm.033704
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
M1WT and M85WT strongly decreased the level of both PTMs of
tubulin. Similar results were obtained by analyzing the protein
expression of cells expressing spastin mutants by western blotting
(Fig. 4C,D). In HeLa cells, detyrosinated and polyglutamylated
tubulin have very low basal levels (Lacroix et al., 2010), and no
changes in these PTMs have been observed in cells expressing
spastin mutants (data not shown). It is interesting to note that the
specific intracellular localization of M1CY and M85CY, and the
associated high level of acetylated tubulin, have been observed
2-4 days after expression of mutant spastin (Fig. S5A,B). We
exceptionally found some HeLa cells still expressing M1CY
1 month after transfection (Fig. S5C). However, after 4-5 days,
almost all spastin-expressing cells die, suggesting a relatively
long-lasting toxic effect for these mutants.
Two enzymes are mainly responsible for the acetylation state
of Lys40 of α-tubulin (Li and Yang, 2015): the first is the
acetyltransferase α-TAT (ATAT1) (Akella et al., 2010), which
adds an acetyl group to this Lys; the second is the histone deacetylase
HDAC6, which deacetylates it (Matsuyama et al., 2002). In order to
understand whether spastin-induced acetylation depends on α-TAT
Fig. 1. Mutated spastins decorate different
subset of MTs in HeLa cells. (A) HeLa cells
expressing mutated GFP-tagged spastins
were fixed and stained for β-tubulin.
Magnifications of typical patterns are shown
in the insets (red outline boxes). The green
outlined inset in M1Δ-GFP shows typical
empty ring-shaped structures observed with
this construct. Scale bars: 20 µm. (B) HeLa
cells that co-expressed M1CY-Flag and
M85CY-GFP were fixed and stained for
β-tubulin (not shown in the overlay). Scale
bar: 10 µm. (C) Quantification of the overlap
between GFP and Flag staining. Acquired
images were processed as described in the
Materials and Methods, and colocalization
analysis between M85CY-GFP and
M1CY-Flag (number of cells analyzed=11)
was performed with ImageJ software.
Colocalization coefficients between
M1CY-GFP and M1CY-Flag are shown for
comparison (number of cells analyzed=13).
Data are shown asmean±s.e.m. Significance
was determined by one-way ANOVA,
Dunnett’s post test. ****P<0.001. (D) HeLa
cells transfected with the M85CY-GFP
complementary DNA (cDNA) were subjected
to live imaging at 37°C for 2 h. Images were
acquired every 5 min. Scale bar: 10 µm.
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activity, the enzymewas silenced by small interfering RNA (siRNA),
as previously described (Mackeh et al., 2014). In comparison to
control and scramble siRNA-transfected cells, α-TAT siRNA limited
significantly the increase in the level of tubulin acetylation induced by
M1CY and M85CY by ∼56% and ∼73%, respectively (Fig. 5B).
Consistent with the fact that tubulin acetylation did not influence
spastin binding to MTs, the intracellular localizations of spastin
mutants were not affected by α-TAT inhibition. Also, the levels of
tyrosinated α-tubulin and that of β-tubulin remained unchanged
(Fig. 5C). On the other hand, we did not observe significant changes
in the catalytic activity of HDAC6 and its expression level in HeLa
cells expressing spastin mutants (Fig. 5D,E).
Taken together, these results demonstrate that mutated spastin
overexpression increases the level of tubulin acetylation in HeLa
cells, likely by enhancing the activity of α-TAT rather than
decreasing that of HDAC6.
Fig. 2. WT and mutated M1 spastin co-
localizewith the ER. (A) HeLa cells expressing
WT and mutated GFP-tagged spastin were
fixed and stained with the ER marker
calreticulin. Images in the insets were
deconvoluted. Scale bars: 20 µm.
(B) Quantification of the overlap between
GFP and calreticulin staining. Acquired images
were processed as described in the Materials
and Methods, and analysis of colocalization
between GFP-tagged spastin constructs
and calreticulin was performed with ImageJ
software. N, number of cells analyzed. Data
are shown as mean±s.e.m. Significance was
determined by one-way ANOVA, Dunnett’s post
test. **P<0.01; ****P<0.001; ns, not significant.
Differences between N-Ter and the other
mutants were always significant (data not
shown).
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M1CY-positive bundles display higher stability than
M85CY-positive bundles
The expression of mutated spastin increases the level of acetylated
tubulin, which is likely to be associated with increased MT stability.
To further explore the properties of the MT bundles that recruit
spastin mutants, cells were treated with MT-depolymerizing agents
or exposed to high ionic strength.
To test whether the M1CY- and M85CY-positive bundles resist
MT depolymerization, cells were first treated by cold shock for
30 min (Ochoa et al., 2011). As shown in Fig. 6, the typical
perinuclear localization of M1CY was retained, whereas M85CY
diffused into the cytoplasm. In this condition, M1Δ bundles were
also lost and a typical ER staining was unmasked, suggesting that it
is still inserted into the membrane of this organelle. Then, raising the
temperature back to 37°C allowed the repolymerization of MTs,
which was achieved after 20 min (data not shown), and a complete
recovery of spastin mutant bundles after 90 min in all the conditions
(Fig. S6). The analysis of the average intensity of acetylated tubulin
in HeLa cells expressing spastin mutants showed that, in M1CY-
positive cells, this signal dropped lower and recovered faster than in
M85CY-expressing cells (Fig. 6B), suggesting a higher stability of
M1CY-decoratedMTs to cold shock.Western blot analysis revealed
that similar behavior was observed in HEK cells treated by cold
shock as in HeLa cells (Fig. 6C). Depolymerization of MTs with
6.6 µM nocodazole for 15 min at 37°C confirmed the higher
resistance of M1CY-positive bundles compared with the M85CY-
positive ones (Fig. S7). Moreover, the depolymerization of MTs
decorated by M1CY was partially prevented compared with
untransfected cells, in keeping with previous findings (Solowska
et al., 2014). We further checked that nocodazole removal allowed
MTs to repolymerize and the rescue of the M85CY typical pattern.
In vitro, the interaction of spastin with MTs is expected to be
dominated by ionic interaction between the positively charged
RKKK-motif in the MTBD of spastin and the negatively charged
‘E-hook’ of tubulin. Indeed, both the landing rate of spastin to MTs
and its dwell time were significantly reduced by increasing ionic
strength (Eckert et al., 2012a). In order to test whether change in
intracellular ionic strength affects the localization of spastin
mutants, medium osmolality was increased up to 500 mOsmol/l
by treating cells with 0.25 M NaCl for 30 min. At this nontoxic
value of osmolality, cells transiently shrink, after which their
volume is quickly rescued (within minutes) by salt influx. As a
result, both macromolecular crowding and intracellular ionic
strength increase (Burg et al., 2007; Nunes et al., 2015). In these
Fig. 3. MutatedM1, but not M85, decorates a
subset of MTs in mouse cortical neurons.
(A) Mouse cortical neurons at 4 DIV were
transfected with GFP-tagged spastin mutants,
fixed after 16 h and stained for acetylated
tubulin. Magnifications show the MT pattern
for M1CY and discontinuous MT decoration
for M1Δ. (B) Mouse cortical neurons were
transfected with M1CY-Flag andM85CY-GFP,
fixed and stained for β-tubulin (not shown in the
overlay). Scale bars: 20 µm.
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conditions, M1CY has a similar behavior observed after MT
depolymerization, with a higher stability compared with that of
M85CY and M1Δ (Fig. 6). Removal of NaCl allows the initiation
of the rescue of typical localization of M85CY after 30 min, which
is completely achieved in 180 min (Fig. S8). On the contrary, a full
M1CY pattern is already observed after 30 min of recovery. NaCl
hypertonic treatment in HeLa cells leads also to a MT network
enriched in acetylated tubulin (Mackeh et al., 2014). However, the
typical localization of spastin mutants was unchanged after
changing the level of this PTM of tubulin by HDAC6 inhibitors
(Haggarty et al., 2003), such as trichostatin-A (TSA) and tubacin
(Fig. S9), or by silencing α-TAT activity (Fig. 5), suggesting that
this mechanism is not implicated in the effects observed here.
Analysis of the average intensity of acetylated tubulin in HeLa
cells expressing spastin mutants showed that the level of this
PTM remains elevated in M1CY cells compared with that of
M85CY or control cells (Fig. 6D). This suggests that M1CY retains
its localization upon NaCl treatment, as confirmed by western
Fig. 4. Spastin mutants increase the level
of acetylated tubulin in HeLa cells.
(A) HeLa cells were transfected with
GFP-tagged spastin mutants, fixed after
16 h and stained for acetylated tubulin.
Scale bars: 20 µm. (B) Quantification
of the average intensity of acetylated or
tyrosinated tubulin in GFP-positive cells
normalized to nontransfected cells (100%).
The number of cells analyzed ranged
between 40 and 200. (C) Representative
western blot of HeLa cells transfected with
the same GFP-tagged constructs as in
panel B (note that the blot was stripped and
re-probed for Fig. 5E). Increase of
acetylated tubulin by treatment with the
deacetylase inhibitors TSA or tubacin are
shown for comparison. The arrowhead
indicates M1CY-GFP, dash indicates
M85CY-GFP and circle indicates M1Δ-GFP.
(D) Quantification of the ratio between
acetylated tubulin and GAPDH from three
independent experiments. Data were
normalized to untransfected cells (control).
Data are shown as mean±s.e.m.
Significance was determined by one-way
ANOVA, Dunnett’s post test. *P<0.05;
**P<0.01; ****P<0.001; ns, not significant.
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blot analysis in HEK cells treated with hypertonic solution
(Fig. 6E). The lower stability of M85CY was further observed by
increasing medium osmolality with 0.3 M sucrose (Fig. S10), a
classical impermeant solute used to produce hypertonicity (Burg
et al., 2007).
These results demonstrated a higher stability of M1CY-positive
bundles compared with that of M85CY. Moreover, these data
suggest that the highest stability is obtained in the presence of both
the N-terminal domain and the AAA cassette needed for ER
localization and hexamer formation, respectively.
M1CY, but not M85CY, re-localizes M1WT to filamentous
pattern
In cells co-expressing mutated and M1WT spastin, a filamentous
instead of a punctuated pattern characterizes M1WT (Errico et al.,
2002; Pantakani et al., 2008). These results suggested that mutated
Fig. 5. Spastin-induced tubulin
acetylation depends on α-TAT activity.
(A) HeLa cells were transfected for 24 h
with siRNA against all isoforms of α-TAT or
siRNA scramble, and co-transfected for
48 h with the same siRNA and GFP-tagged
mutated spastin. Cells were fixed after
72-96 h of siRNA treatment and stained for
acetylated tubulin. Red arrows indicate the
effect of siRNA treatment on acetylated
tubulin in mutated spastin-expressing cells.
Scale bars: 20 µm. (B) Quantification of
the average intensity of acetylated tubulin in
the different experimental conditions.
Data are normalized to untreated and
nontransfected cells (100%). The number
of cells analyzed ranged between 20 and
73. (C) Quantification of the average
intensity of tyrosinated and β-tubulin
in the same experimental conditions.
(D) Quantification of HDAC6 catalytic
activity. HeLa cells were transfected with
GFP-tagged spastin mutants, GFP as
control or mock transfected (control), and
the catalytic activity of the enzyme HDAC6
was measured using a HDAC6 activity
fluorometric assay (Biovision), according to
the manufacturer’s instructions. Data are
the average of 13-16 replicates from four
independent experiments and represented
as a percentage of the control condition.
(E) Representative immunoblot of HeLa
cells transfected with spastin GFP-tagged
constructs. The expression level of HDAC6
protein was not altered by spastin
expression. The arrowhead indicates
M1CY-GFP, dash indicates M85CY-GFP
and circle indicates M1Δ-GFP. Blot from
Fig. 2C was stripped and re-probed for the
proteins shown; the same control blot is
used in both figures. Data are shown as
mean±s.e.m. Significance was determined
by one-way ANOVA, Dunnett’s post test.
*P<0.05; ****P<0.001; ns, not significant.
NT, not treated.
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spastin can recruit and/or interact with the M1WT isoform and
support the negative gain-of-function mechanisms for some
missense mutations of spastin (Solowska and Baas, 2015).
However, whether M1 and M87 can form heterohexamers, and
whether mutated M87 can also recruit M1WT, is still unknown. To
address this question, HeLa cells were co-transfected with M1WT-
Flag andWT or mutated GFP-tagged spastin. Only cells with low or
moderate levels of M1WT and reduced severing of MTs were
selected. In agreement with previous observations, M1WT-Flag
acquires a filamentous pattern when co-expressed with M1CY.
In this condition, Flag- and GFP-positive bundles significantly
overlap, as demonstrated by colocalization analysis (Fig. 7A,B). On
the contrary, M85CY-positive bundles did not colocalize with
M1WT-Flag, which retains its typical punctate and perinuclear
pattern. Co-expression ofM1ΔwithM1WT results in the loss ofMT
decoration of the former and its partial colocalization with M1WT.
As expected, M1WT-Flag fully colocalizes with M1WT-GFP. A
co-immunoprecipitation approach confirmed that M1WT strongly
Fig. 6. M1CY-positive bundles, but
not M85CY-positive or M1Δ-positive
bundles, are resistant to cold-shock
or NaCl treatments. (A) HeLa cells
expressing mutated spastin were
subjected to cold shock for 30 min or
incubated with 0.25 M NaCl for 30 min
at 37°C and fixed. Scale bars: 20 µm.
(B,C) HeLa cells expressing M1CY or
M85CY were treated as described above
and fixed after treatments (0 min), or
at different time points (30, 60, 90, 120
and 180 min) after the recovery of
temperature at 37°C (B) or the restoration
of extracellular normal ionic strength (C).
Untreated cells were taken as the control
condition (Ctrl). HeLa cells were then
stained for acetylated tubulin (see also
Figs S5 and S7), and the average
intensity of staining was measured in
spastin-positive or nontransfected cells
(nonpositive) and plotted over time.
Values were normalized to untransfected
cells before treatments. The number of
cells analyzed ranged between 20 and
115. Data are shown as mean±s.e.m.
Significance differences between M1CY
and M85CY curves were determined by
two-way ANOVA, Dunnett’s post test.
*P<0.05; **P<0.01; ***P<0.005;
****P<0.001. (D,E) Representative
immunoblot of HEK cells expressing
GFP-tagged spastins or GFPas a control
(data not shown) and treated by cold
shock (D) or incubated with 0.25 M NaCl
(E), as described above for HeLa cells.
The lower panels show the quantification
of acetylated tubulin/GAPDH ratio based
on the integrated fluorescence intensity
of the respective western blot bands and
normalized to the values measured in
GFP-expressing cells without treatment.
Data represent the average of two
independent experiments
(mean±s.e.m.). Acetylated tub.,
acetylated tubulin.
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interacts with the long transcript of M1CY construct, but not with
N-Ter or cytosolic GFP (Fig. 7C). A very weak band was observed
for M85CY. Although M1Δ partially colocalized with M1WT, we
did not observe a significant interaction between them, confirming
the role of AAA domain in the hexamerization process of spastin.
These results show that only M1CY re-localizes and interacts with
M1WT and that this interaction strictly depends on the AAA
domain of spastin.
M1 mutants impair axonal transport
Defective axonal transport has been extensively associated with
reduction of spastin activity in HSP-SPG4 neuronal models (Kasher
et al., 2009; Denton et al., 2014; Havlicek et al., 2014; Plaud et al.,
2017). However, very few studies addressed the effect of mutated
spastin on axonal transport in neurons. In squid axoplasm and
SHS5Y cells, fast axonal transport (FAT) is regulated by M1
lacking the AAA cassette (Solowska et al., 2008), and also by M1
Fig. 7. M1CY interacts with M1WT and re-
localizes it to a filamentous pattern. HeLa or
HEK cells were co-transfected with GFP-tagged
mutated spastins and Flag-tagged M1WT for
16 h. (A) HeLa cells were fixed and stained
with anti-Flag mAb. Scale bars: 20 µm.
(B) Quantification of the overlap between Flag
and GFP staining. Acquired images were
processed as described in the Materials and
Methods. For colocalization analysis between
M1-Flag and M1CY-GFP, only cells with
filamentous pattern of M1-Flag were selected.
N, number of cells analyzed. Data are shown as
mean±s.e.m. Significance was determined by
one-way ANOVA, Dunnett’s post test.
****P<0.001. ns, not significant. Differences
between M1 and the other mutants were always
significant (data not shown). (C) HEK cells were
lysed and protein extract was incubated with
Anti-Flag M2magnetic beads at 4°C for 12-16 h.
Only M1CY-GFP co-immunoprecipitates with
M1WT. HC, heavy chains; WB, western blot.
The arrowhead indicates M1CY-GFP, dash
indicates M85CY-GFP, circle indicates
M1Δ-GFP, square indicates N-Ter-GFP and
asterisk indicates GFP.
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carrying different missense mutations (Leo et al., 2017).
Interestingly, in these models, mutated M87 did not affect FAT.
We have recently demonstrated that the v-SNARE VAMP7 traffic is
altered in SPG4 KO neurons (Plaud et al., 2017). In order to study
whether the overexpression of M1 spastin mutants regulates
VAMP7 traffic, we co-transfected cortical neurons at 5 DIV with
RFP-VAMP7 and GFP-tagged spastin mutants or cytosolic GFP as
a control (Fig. 8). The number of moving VAMP7 vesicles, their
Fig. 8. MutatedM1 spastin alter axonal transport in cortical neurons. (A) Cortical neurons at 5 DIV were co-transfected with GFP-taggedmutated spastin and
RFP-VAMP7 and imaged live after 16-20 h. The dynamics of VAMP7-positive vesicles were analyzed along the longer proximal axonal segment decorated by
mutated M1 using a kymograph. (B) In GFP-, N-Ter- or M85CY-expressing cells, a similar region of axons was analyzed. (C,D) Quantification of anterograde
(C) and retrograde (D) average speeds of RFP-VAMP7-containing vesicles in the different experimental conditions. n, number of moving vesicles analyzed.
(E) Quantification of the number of moving VAMP7-positive vesicles normalized to the length of the axonal segment analyzed in GFP-, M1Δ- and
M1CY-expressing neurons. a, number of axons analyzed. (F) Quantification of run length average of anterograde and retrograde VAMP7 moving vesicles
(over 3 µm). d, number of vesicle displacements between two pauses analyzed. (G) Cumulative frequency distribution (%) of vesicle run lengths moving in
anterograde (left) or retrograde (right) directions. Data are shown asmean±s.e.m. Significancewas determined by one-way ANOVA, Dunnett’s post test. *P<0.05;
**P<0.01; ***P<0.005; ****P<0.001; ns, not significant. Scale bars: 20 µm.
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speed and direction were measured by kymographs along the
portions of axons decorated by M1 mutated spastin (Fig. 8B;
Movie 2), as well as in an analogous segment of axons in neurons
expressing M85CY, N-Ter or GFP. The statistical analysis suggests
that M1Δ and M1CY significantly impair both the anterograde
(0.72±0.04 µm/s, 0.43±0.03 µm/s, 0.53±0.04 µm/s for GFP,
M1Δ and M1CY, respectively) and retrograde (0.71±0.02 µm/s,
0.48±0.02 µm/s, 0.5±0.03 µm/s for GFP, M1Δ and M1CY,
respectively) velocities of VAMP7-positive vesicles compared
with the control, and also with M85CY- and N-Ter-expressing
neurons (Fig. 8C,D). In addition, the amount of moving VAMP7
vesicles (expressed as number of vesicles/µm of axonal segment
analyzed; 0.072±0.006, 0.050±0.004, 0.063±0.007 for GFP, M1Δ
and M1CY, respectively) and their run length (10.74±0.44 µm,
8.55±0.32 µm, 8.46±0.36 µm for GFP, M1Δ and M1CY,
respectively) were significantly reduced in M1-expressing neurons
(Fig. 8E-G). These results suggest a selective effect of mutated M1
isoforms on axonal cargo motility.
DISCUSSION
Unraveling the role and the contribution of each isoform of spastin
to HSP-SPG4 is likely to be crucial for understanding the etiology
of this disease. Nowadays, the exact intracellular distribution of
spastin and the subset of MTs targeted by this protein in cell are not
yet well known. Studying the localization of overexpressed WT
spastin in cell models could be biased by its massive MT-severing
activity, which results in change in cell morphology. Thus, stable
inactive mutated spastin, such as missense mutations within the
AAA cassette, could be an alternative approach to investigate
the biophysical properties of the two isoforms of this protein. In this
work, we analyzed the missense mutation C448Y (C445Y in mice)
previously described (Errico et al., 2002; White et al., 2007;
Solowska et al., 2014; Leo et al., 2017), and confirmed that mutated
M1 (M1CY) decorates and bundles a subset of perinuclear MTs in
HeLa cells (White et al., 2007; Solowska et al., 2014). Similarly, in
mouse cortical neurons, M1CY decorates a subset of MTs at the
proximal axons and dendrites. Unexpectedly, we observed that
the short isoform of spastin M87 (M85 in mouse) harboring the
same mutation (M85CY) decorates a different subset of MTs in
HeLa cells, whereas in cortical neurons it is essentially cytosolic.
M85CY-positive bundles appeared to be thicker than those that
were positive for M1CY and were often clustered at the cell
periphery. Interestingly, M85CY directly decorates peripheral MTs,
suggesting that its localization is not the result of decorated MTs
nucleated at the centrosome, and that it is actively transported
along longer MTs by molecular motors (Ahmad and Baas, 1995;
Mogensen et al., 2000; Abal et al., 2002; Baas andMozgova, 2012).
Previous observations in RTL-6 fibroblasts (Solowska et al., 2014)
and COS-7 cells (Errico et al., 2004) suggested that missense
mutations of M87, C448Y and K388R were mainly cytosolic.
However, our results are in agreement with the observations in S2
cells of Drosophila Spastin lacking the N-terminal domain and
harboring different missense mutations (Roll-Mecak and Vale,
2005). Thus, mutated M87 can also decorate and bundle MTs, and
this seems to happen/occur in a cell-specific manner that might not
be relevant in cortical neurons.
As expected, M1CY-positive bundles overlap with the ER,
whereas M85CY-positive bundles do not, but the insertion of
M1CY into ER membranes is not sufficient to account for its
perinuclear localization. Indeed, the N-terminal domain of spastin,
but also M1Δ, which lacks the AAA cassette but contains the
N-terminal region, localizes to larger extents with the ER network
(Fig. 2). In addition, the level of MT acetylation, a PTM of tubulin
concentrated at the cell center in several cell lines (Piperno et al.,
1987), is not critical for the localization of M1CY or for those of
M85CY and M1Δ (Fig. 5; Fig. S9). Moreover, M1Δwould decorate
and bundle MTs, uniformly in HeLa cells and distally and less
discontinuously than M1CY in neurons, suggesting that the
presence of the AAA cassette is mandatory for the proximal
localization of M1 mutants. Thus, the perinuclear localization of
M1CY might result from cooperation between the N-terminal
domain, the MTBD and the AAA cassette. The determinants of
M85CY localization are more puzzling as this mutant decorates
mainly a peripheral subset ofMT bundles, indicating that its binding
to MTs is regulated by parameters other than just the affinity of
the MTBD (White et al., 2007) for MTs. To model our results, the
interaction of cytosolic M85CY with a specific subset of MTs, not
involved in ER dynamics, facilitates the formation of oligohexamers
of M85CY (Eckert et al., 2012b) and hence bundling of MTs. On
the contrary, both M1CY and M1Δ span the outer leaflet of ER
membrane and simultaneously interact with MTs. Consequently,
they may crosslink different ER tubules and bundle MTs. However,
M1Δ, unlike M1CY, cannot form hexamers and interacts at most
with only oneMT at a time, likely forming less complex interactions
between ER andMTs thanM1CY. In this context, the lower stability
observed for M85CY-positive bundles compared with that of
M1CY-positive bundles can be explained by an increased stability
of the hexameric structure of the latter as a result of insertion in the
ER. The different behavior between M1CY and M1Δmight depend
on the number of MTs involved and hence crosslinks between MTs
and ER. Additional investigation will be needed to fully unravel the
molecular mechanisms involved in the specific intracellular
localization of these mutants. We could not exclude that isoform-
specific molecular partners of spastin contribute to the different
localization of M1CY and M85CY.
Increased level of acetylated tubulin has previously been
associated with defective spastin expression in neurons (Orso
et al., 2005; Denton et al., 2014; Plaud et al., 2017). Interestingly, all
spastin mutants led to a significant increase of this PTM of tubulin
in HeLa and HEK cells. Our results are in agreement with previous
observations (Evans et al., 2005) and are similar to the effect of
overexpression of other MAP bundling proteins, such as MAP2c
(MAP2) and Tau (MAPT) (Takemura et al., 1992). The increased
level of acetylated tubulin is also observed in MTs that are not
decorated by spastin mutants (Fig. 4; Fig. S5), suggesting the
activation of signaling pathways likely involving the
acetyltransferase α-TAT (Fig. 5), rather than the deacetylase
HDAC6, which result in a hyperstabilization of the entire MT
network. Because acetylation of tubulin has an important role in
several cellular processes, including axonal transport, its spastin-
induced enrichment might be implicated in the neurodegeneration
process of HSP-SPG4. However, we were not able to confirm a
similar effect in cortical neurons expressing M1 mutants (data not
shown). This is likely due to the extremely high level of this PTM in
neurons, or different mechanisms of regulation of PTMs of tubulin
in these cells compared with endothelial cells. It is interesting to
note that transgenic Drosophila bearing a K467R mutation in
Spastin presented a hyperstabilization of the MT network (Orso
et al., 2005). This mutation corresponds to K388R in human spastin
protein which, similarly to C448Y, constitutively bindsMTs (Errico
et al., 2002; Evans et al., 2005).
Dominant-negative effect of mutated spastin is thought to be
dependent on its co-assembly with WT spastin into hexamer rings
(Le et al., 2013), which leads to a decreased catalytic turnover rate of
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the enzyme (Eckert et al., 2012b). Different studies (Errico et al.,
2002; Pantakani et al., 2008), including our results, demonstrated
that the punctuated pattern of M1WT was relocalized on MTs
decorated by missense mutated M1 and interacts with it, supporting
this mechanism. We further demonstrated that M1WT was not
recruited by mutated M85 or spastin lacking the AAA cassette,
suggesting a potential higher toxicity of mutated long isoforms of
spastin. However, in human patients, missense SPG4 AAA
mutations do not lead to more severe symptoms compared with
other mutations. A recent mouse model knocked in for a spastin
ATPase missense mutation (Allison et al., 2017) revealed several
subtle abnormalities in homozygous, but not in heterozygous,
mutant mice. Moreover, experimental evidence that MT severing is
downregulated by hetero-oligomers of mutated and WT spastin are
still lacking. Indeed, an in vitro study reported that inactive M1
mutant inhibits both the enzymatic activity and the pre-severing
phase, but not the actual MT-severing phase (Eckert et al., 2012b).
In addition, mutated M1 or M87 does not prevent MT-severing
activity by M87 spastin in fibroblasts (Solowska et al., 2014). Our
unpublished results confirmed that the expression of all mutants
analyzed in this work did not reduce the MT-severing activity
of M1WT and M85WT in HeLa or HEK cells. An alternative
hypothesis is that decorated MTs acquire ‘pathological’ biophysical
properties, such as their degree of stabilization or fasciculation,
which alter, for example, the transport of cargos within the
axons. Indeed, the traffic of VAMP7-positive vesicles was
strongly impaired along MTs decorated by M1CY, as well as
those decorated by M1Δ, which is unable to form hexamers (Figs 7
and 8). These data suggest that the effects observed here are
independent of the MT-severing activity of spastin and are in
agreement with the inhibitor effects of M1 lacking the AAA
domain, both on FAT and traffic of synaptophysin observed in
axonal squid and SH-SY5Y cells, respectively (Solowska et al.,
2008; Leo et al., 2017). A possible mechanism underlying these
observations, already proposed by McDermott and co-authors
(McDermott et al., 2003), is that mutated M1 impairs vesicular
motility by altering the interaction between the molecular motors,
such as kinesins and dynein, and MTs by coating their surface.
Indeed, our data are in agreement with the observations that
overexpression of MAPs that promote MT bundling and
stabilization, such as Tau, MAP2 or MAP4, alter membrane
transport by regulating the motility of kinesin motors (Seitz et al.,
2002; Atherton et al., 2013). For instance, Tau expression reduces
the fraction of moving APP vesicles and their velocities in cultured
neurons (Stamer et al., 2002), similar to the observed effect on
VAMP7 traffic (Fig. 8). However, there is no consensus concerning
the molecular mechanisms(s) for effects of these MAPs on vesicular
transport. Moreover, cargo velocities should not be affected by
MAP-MT interaction once motors are in motion, which is in
contrast to our observations for VAMP7 vesicles (Fig. 8C). To
complicate the interpretation of our data, the level of tubulin
acetylation, which is increased by mutated spastin, at least in cell
models, regulates the interaction and distribution of MAPs
themselves (Atherton et al., 2013) and the binding of kinesin-1
motors to MTs and their activity (Reed et al., 2006). Further
investigation will be necessary to understand how mutated M1
spastins impair axonal transport.
Finally, we speculate that the proximal axonal localization of
mutated M1 spastins, particularly M1CY, suggests they regulate the
MT array of this region that partially overlaps with the axonal initial
segment (AIS). In theAIS,MTs aremore tightly packed into fascicles
and contribute to its function of intracellular selective filtering by
forming oriented tracks for active vesicular transport (Jones and
Svitkina, 2016). Interestingly, TRIM46, a recently discovered protein
localized in the AIS, induces MT bundles in HeLa cells and
contributes to formation and maintenance of AIS MT fascicles (van
Beuningen et al., 2015). In pathological conditions, a low level of
mutated M1 can accumulate over time in the AIS, altering its MT
array and filter function, and hence the axonal transport.
In conclusion, we demonstrated that mutated full-length M1
hyperstabilizes the MT network and bundles a subset of MTs
characterized by a higher stability compared with that decorated by
mutated M87. In addition, mutated M1 has the unique ability to
interact with the WT form of the protein, decorates proximal MTs
within the axon and impairs the vesicular transport. Our results
highlight clear distinct features between the two isoforms of spastin
bearing a pathogenic missense mutation associated with HSP-SPG4,
and support potentially different roles forM1 andM87 in the etiology
of this disease, at least for mutated spastins which may act via a
dominant-negative or gain-of-function pathological mechanism.
MATERIALS AND METHODS
Antibodies and dyes
Mouse monoclonal Ab (mAb) anti-acetylated tubulin (1:1000-1:100,000,
clone 6-11B-1), anti-GAPDH (1:5000), and mouse mAb anti-Flag (1:500-
1:2000, clone M2) were from Sigma-Aldrich (St Louis, MO, USA). Mouse
mAb anti-GFP (1:500-1:2000, clones 7.1 and 13.1) was from Roche (Basel,
Switzerland). Rabbit polyclonal antibody (pAb) anti-GFP (1:1000, 2555)
was from Cell Signaling Technology (Danvers, MA, USA). Rat mAb anti-
tyrosinated tubulin (1:1000-1:10,000, clone YL1/2) was from Millipore
(Burlington, MA, USA). Mouse mAb anti-β-tubulin (1:1000-1:5000) was
produced from the American Type Culture Collection E7 hybridoma clone.
Rabbit pAb anti-β-tubulin was from Abcam (Cambridge, UK). Rabbit pAb
anti-calreticulin (1:750, PA3-900) was from Thermo Fisher Scientific
(Waltham, MA, USA). Rabbit pAb anti-HDAC6 (1:500, H300) was from
Santa Cruz Biotechnology (Dallas, TX, USA). Secondary antibodies for
immunofluorescence (1:500) Alexa Fluor 488-, 594-, 647-conjugated goat
anti-rabbit, anti-mouse, anti-rat or donkey anti-goat were from Molecular
Probes (Carlsbad, CA, USA). Secondary antibodies (1:10,000) for
immunoblot IRDye 800CW- or IRDye 680CW-conjugated goat anti-
rabbit, anti-mouse or anti-rat were from LI-COR Biosciences (Lincoln, NE,
USA). BODIPY 493/503 was from Molecular Probes.
cDNA, reagents and drug treatments
Mouse cDNA encoding full-length spastin (M1; clone MGC: 54786, clone
sequence BC046286.1) was cloned in EGFP-N1 (Clontech, Mountain View,
CA, USA) or pCMV-FLAG-MAT-Tag-2 expression vector (Sigma-Aldrich)
or mCherry-N1 (a generous gift from Roger Tsien, University of California
SanDiego, SanDiego,CA,USA). cDNA lacking the first 84 aa (M85), cDNA
encoding M1 lacking the AAA ATPase cassette (aa 1-338; M1Δ) and cDNA
encoding the first 84 aa (N-Ter) were amplified from theM1 construct by PCR
using specific primers and cloned in EGFP-N1 or mCherry-N1. To generate
point mutation c.445C>Y inM1 andM85 constructs, the QuickChange II XL
site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA)
was used according to themanufacturer’s instructions. The correct sequence of
all constructs and the presence of the point mutation were verified by DNA
sequencing. mRFP-VAMP7 was previously described (Burgo et al., 2009;
Tsaneva-Atanasova et al., 2009). Tubulin-m-Cherry was a generous gift from
Roger Tsien.
Sucrose (Sigma-Aldrich), nocodazole (Sigma-Aldrich), tubacin (Tocris,
Bristol, UK) or trichostatin A (TSA; Tocris) were added to culture medium
at different final concentrations. When needed, drugs were kept as stock
solution in dimethyl sulfoxide and working dilutions were prepared freshly
on each day of the experiment.
Cell lines, cDNA transfection and siRNA knockdown
HeLa or HEK cells were plated on uncoated 12 mm or 30 mm glass
coverslips or 60 mm petri dishes and maintained in Dulbecco’s modified
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Eagle medium supplemented with 10% fetal bovine serum and antibiotics
(penicillin-streptomycin; Gibco, Carlsbad, CA, USA) at 37°C and 5% CO2.
Cells were transfected at 60-70% density with Lipofectamine 2000 (Life
Technologies, Carlsbad, CA, USA) or Turbofect (Thermo Fisher Scientific)
according to the manufacturer’s instructions. For siRNA α-TAT knockdown
experiments HeLa cells were treated as previously described (Mackeh et al.,
2014). Briefly, cells were transfected twice with 75 nM ON-TARGET plus
human ATAT1 siRNA SMART pool (Dharmacon, Lafayette, CO, USA)
using DharmaFECT1 transfection reagent. Cells were co-transfected
again 72 h after the first siRNA transfection with siRNAs and
spastin-GFP constructs using Lipofectamine2000 and processed for
immunofluorescence after 16-24 h. A nontargeting siRNA (scramble) and
mock transfection were used as controls.
HDAC6 activity assay
AHDAC6 activity assay (K466; Biovision, Milpitas, CA, USA) was used to
assess HDAC6 activity in protein samples extracted from HeLa cells
expressing mutated spastin according to the manufacturer’s instructions.
Briefly, sample proteins (20-30 μg) were treated with or without HDAC6-
selective inhibitor tubacin (2 µM) and then incubated with a synthetic
acetylated-peptide substrate coupled to an AFC fluorophore for 30 min at
37°C in 5%CO2. Deacetylase activity of HDAC6 results in the release of the
fluorophore, for which fluorescence intensity (excitation/emission=380/
490 nm) was quantified using the Varioskan LUX microplate reader
(Thermo Fisher Scientific). HDAC6 catalytic activity is shown as a relative
percentage compared with that of mock transfected cells.
Experimental mice
The mouse strain used in this work was housed and bred in the SPF rodent
facility CERFE Genopole (Evry, France). The facility is accredited as a user
establishment by the French Ministry of Agriculture and Food under D-91-
228-107 and has the quality system certification ISO 9001 v2015. Mouse
colonies were monitored quarterly by direct test methods following Felasa
recommendations. Protocols that involved animals for scientific use were
approved by the French Ministry of High Education and Research. Animal
experiments were performed according to the directive of the European
parliament and of the council of 22 September 2010 (2010/63/UE).
Primary culture of cortical neurons and their genotyping
Primary culture of cortical neurons was prepared from embryonic mice
(E17) and described previously (Burgo et al., 2012; Fassier et al., 2013).
Briefly, brains were dissected in Hank’s balanced salt solution with Hepes
(Invitrogen, Carlsbad, CA, USA) and incubated with 0.25% trypsin
(Invitrogen) for 15 min at 37°C. Cells were than dissociated through a
fire-constricted Pasteur pipette in the presence of DNase (0.1 mg/ml; Sigma-
Aldrich). Neurons were plated at a density of 50,000-100,000 or 500,000 on
12 mm or 30 mm, respectively, poly-DL-ornithine-coated (Sigma-Aldrich)
glass coverslips in minimal essential medium (Gibco, Invitrogen)
supplemented with 10% horse serum, 0.6% glucose, 2 mM glutamine,
and 10 IU/ml penicillin-streptomycin. Neurons were grown and maintained
in Neurobasal mediumwithout Phenol Red (Invitrogen), supplemented with
2% B27 and 2 mM L-glutamax (Invitrogen) for 3-5 days and then
transfected and processed for analysis. Embryo genotypes were identified
as described previously (Plaud et al., 2017). Heterozygous embryos were
selected to mimic the HSP pathology.
Immunofluorescence, integrated fluorescence and
colocalization analysis
Cells were fixed with 4% paraformaldehyde-sucrose for 20 min at room
temperature and then processed for immunofluorescence. Average intensity
of acetylated, tyrosinated or β-tubulin in single HeLa cells was measured by
using Metamorph software (Roper Scientific, Evry, France) in pre-selected
cells expressing mild levels of GFP-tagged spastin and having good
morphology. Data were normalized to the average intensity of tubulins of
untransfected and/or untreated cells. Each experiment was repeated between
two and six times. The number of cells analyzed ranged between 40 and 200.
For colocalization analysis of GFP-tagged spastin with calreticulin or
M1WT-Flag, images were acquired with a Leica DM4B microscope
equipped with light fiber source, a 63×/1.3 NA HC PL Fluotar oil-
immersion objective, a 1.6× tube lens and an Orca Flash 4.0 LT digital
camera (Hamamatsu, Massy, France). Each channel was then processed for
background subtraction and 2D deconvolution with Metamorph software in
order to improve the signal-to-background ratio. Images were then analyzed
with the threshold colocalization plugin in ImageJ (http://imagej.nih.gov/ij/).
Data are the mean from 10-35 cells. Statistical significance was determined
using GraphPad Prism software.
Immunoblot assays, immunoprecipitation and
densitometry analysis
HeLa or HEK cells were lysed 18-24 h after transfection in TSE (50 mMTris
HCl pH 8.0, 150 mMNaCl, 1 mMEDTA), towhich was added 1%Triton X-
100 and protease inhibitor cocktail (Complete ULTRA Tablets, EDTA-Free,
Roche) on ice. For immunoprecipitation experiments, 1 mg protein extract
was incubated overnight in a rotator at 4°C with 50 µl Anti-Flag M2magnetic
beads (Sigma-Aldrich). After several washes, bound proteins were eluted in
SDS sample buffer. Between 40 µg and 60 µg lysates were separated by SDS-
PAGE by using NovexWedgewell 4-20% Tris Glycine (Invitrogen), and then
the proteins were transferred onto nitrocellulose membrane (Amersham
Protran, GE Healthcare Life Sciences). After incubation in 5% nonfat dry
milk in Tris-buffered saline containing Tween [TBS-T; 200 mMTris, 0.15 M
NaCl (TBS), 0.1% Tween 20, pH 7.3] membranes were incubated overnight
with specific primary antibodies. After washing in TBS-T, the membranes
were blotted with secondary antibodies (IRDye 680 or IRDye 800 conjugated;
LI-COR Biosciences). Detection was carried out by an Odyssey infrared
imaging system (LI-COR Biosciences). When needed, the integrated area of
each band was quantified by densitometry analysis using ImageJ software.
The ratio of acetylated versus GAPDH was then calculated for each sample.
Data were normalized to the acetylated/GAPDH ratio value obtained from
nontransfected or GFP-expressing cells on the same experimental day.
Time-lapse imaging and tracking analysis
Cortical neurons were co-transfected between 4 DIV and 6 DIV with 1.5 µg
GFP-tagged spastin mutants and RFP-VAMP7 and 3 µl Lipofectamine2000
(Life Technologies) according to the manufacturer’s instructions. Medium
was replaced after 3 h by astrocyte-conditioned Neurobasal completed
medium to reduce the toxicity of Lipofectamine2000. Time-lapse
experiments were performed between 16 and 24 h after transfection using
an inverted microscope Nikon Eclipse Ti equipped with Intensilight
C-HGFI fiber source, a 60×/1.4 NA Plan-Apochromat oil-immersion Nikon
objective, a 1.6× tube lens and a Neo-sCMOS digital camera (ANDOR,
Belfast, Northern Ireland). Neurons were imaged every 1 s over a time
period of 2 min. A snapshot of the GFP channel was taken to visualize the
segment(s) of the neurites decorated by mutated spastins. Imaging was
conducted in modified Krebs-Ringer-HEPES buffer (135 mM NaCl,
2.5 mM KCl, 1.2 mM MgCl, 2 mM CaCl2, 20 mM HEPES and 11.1 mM
glucose, pH 7.4). Temperature was controlled by warmed air (37°C). RFP-
VAMP7 vesicles were tracked along the proximal region of the longest
neurite (i.e. the axon) decorated by mutated spastins for an average length
of 100 µm by kymograph (Metamorph, Roper Scientific). Speed and
direction of vesicles were quantified by measuring the slope of the
projection of the maximum intensity of fluorescence over the time obtained
by kymograph. Run length of the individual vesicle was calculated by
measuring its displacement (over 3 μm) between two pauses. The number
of moving vesicles was measured manually and normalized to the length of
axon segment analyzed. Average data represent between 40 and 117 vesicles
from 20 to 39 different neurons collected from six neuronal cultures of
heterozygous embryos. Statistical significance was determined using
GraphPad Prism software.
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Plaud, C., Joshi, V., Marinello, M., Pastré, D., Galli, T., Curmi, P. A. andBurgo, A.
(2017). Spastin regulates VAMP7-containing vesicles trafficking in cortical
neurons. Biochim. Biophys. Acta 1863, 1666-1677.
Reed, N. A., Cai, D., Blasius, T. L., Jih, G. T., Meyhofer, E., Gaertig, J. and
Verhey, K. J. (2006). Microtubule acetylation promotes kinesin-1 binding and
transport. Curr. Biol. 16, 2166-2172.
Roll-Mecak, A. and Vale, R. D. (2005). The Drosophila homologue of the hereditary
spastic paraplegia protein, spastin, severs and disassembles microtubules.
Curr. Biol. 15, 650-655.
14
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033704. doi:10.1242/dmm.033704
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Roll-Mecak, A. and Vale, R. D. (2008). Structural basis of microtubule severing by
the hereditary spastic paraplegia protein spastin. Nature 451, 363-367.
Salinas, S., Carazo-Salas, R. E., Proukakis, C., Cooper, J. M., Weston, A. E.,
Schiavo, G. and Warner, T. T. (2005). Human spastin has multiple microtubule-
related functions. J. Neurochem. 95, 1411-1420.
Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E. M., Song, Y. H. andMandelkow, E.
(2002). Single-molecule investigation of the interference between kinesin, tau and
MAP2c. EMBO J. 21, 4896-4905.
Solowska, J. M. and Baas, P. W. (2015). Hereditary spastic paraplegia SPG4: what
is known and not known about the disease. Brain 138, 2471-2484.
Solowska, J. M., Morfini, G., Falnikar, A., Himes, B. T., Brady, S. T., Huang, D.
and Baas, P. W. (2008). Quantitative and functional analyses of spastin in the
nervous system: implications for hereditary spastic paraplegia. J. Neurosci. 28,
2147-2157.
Solowska, J. M., Garbern, J. Y. and Baas, P. W. (2010). Evaluation of loss of
function as an explanation for SPG4-based hereditary spastic paraplegia. Hum.
Mol. Genet. 19, 2767-2779.
Solowska, J. M., D’Rozario, M., Jean, D. C., Davidson,M.W., Marenda, D. R. and
Baas, P.W. (2014). Pathogenic mutation of spastin has gain-of-function effects on
microtubule dynamics. J. Neurosci. 34, 1856-1867.
Solowska, J. M., Rao, A. N. and Baas, P. W. (2017). Truncating mutations of
SPAST associated with hereditary spastic paraplegia indicate greater
accumulation and toxicity of the M1 isoform of spastin. Mol. Biol. Cell 28,
1728-1737.
Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.-M. (2002).
Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and
enhances oxidative stress. J. Cell Biol. 156, 1051-1063.
Takemura, R., Okabe, S., Umeyama, T., Kanai, Y., Cowan, N. J. and Hirokawa, N.
(1992). Increased microtubule stability and alpha tubulin acetylation in cells
transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J. Cell
Sci. 103, 953-964.
Tsaneva-Atanasova, K., Burgo, A., Galli, T. and Holcman, D. (2009). Quantifying
neurite growth mediated by interactions among secretory vesicles, microtubules,
and actin networks. Biophys. J. 96, 840-857.
van Beuningen, S. F. B., Will, L., Harterink, M., Chazeau, A., van Battum, E. Y.,
Frias, C. P., Franker, M. A. M., Katrukha, E. A., Stucchi, R., Vocking, K. et al.
(2015). TRIM46 controls neuronal polarity and axon specification by driving the
formation of parallel microtubule arrays. Neuron 88, 1208-1226.
White, S. R., Evans, K. J., Lary, J., Cole, J. L. and Lauring, B. (2007). Recognition
of C-terminal amino acids in tubulin by pore loops in Spastin is important for
microtubule severing. J. Cell Biol. 176, 995-1005.
15
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm033704. doi:10.1242/dmm.033704
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
